company background image
CXXI

C21 Investments CNSX:CXXI Stock Report

Last Price

CA$0.39

Market Cap

CA$46.2m

7D

16.7%

1Y

-44.2%

Updated

30 Nov, 2022

Data

Company Financials
CXXI fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance3/6
Financial Health4/6
Dividends0/6

CXXI Stock Overview

C21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States.

C21 Investments Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for C21 Investments
Historical stock prices
Current Share PriceCA$0.39
52 Week HighCA$0.81
52 Week LowCA$0.25
Beta2.73
1 Month Change28.33%
3 Month Change10.00%
1 Year Change-44.20%
3 Year Change-48.67%
5 Year Change-63.68%
Change since IPO-99.38%

Recent News & Updates

These 4 Measures Indicate That C21 Investments (CSE:CXXI) Is Using Debt Reasonably Well

Nov 29
These 4 Measures Indicate That C21 Investments (CSE:CXXI) Is Using Debt Reasonably Well

C21 Investments Inc. (CSE:CXXI) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

Oct 12
C21 Investments Inc. (CSE:CXXI) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

A Look At The Fair Value Of C21 Investments Inc. (CSE:CXXI)

Apr 22
A Look At The Fair Value Of C21 Investments Inc. (CSE:CXXI)

Recent updates

These 4 Measures Indicate That C21 Investments (CSE:CXXI) Is Using Debt Reasonably Well

Nov 29
These 4 Measures Indicate That C21 Investments (CSE:CXXI) Is Using Debt Reasonably Well

C21 Investments Inc. (CSE:CXXI) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

Oct 12
C21 Investments Inc. (CSE:CXXI) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

A Look At The Fair Value Of C21 Investments Inc. (CSE:CXXI)

Apr 22
A Look At The Fair Value Of C21 Investments Inc. (CSE:CXXI)

Does C21 Investments (CSE:CXXI) Have A Healthy Balance Sheet?

Mar 22
Does C21 Investments (CSE:CXXI) Have A Healthy Balance Sheet?

C21 Investments' (CSE:CXXI) Solid Earnings May Rest On Weak Foundations

Oct 05
C21 Investments' (CSE:CXXI) Solid Earnings May Rest On Weak Foundations

We Think C21 Investments (CSE:CXXI) Can Stay On Top Of Its Debt

Sep 03
We Think C21 Investments (CSE:CXXI) Can Stay On Top Of Its Debt

C21 Investments (CSE:CXXI) Seems To Use Debt Quite Sensibly

Mar 07
C21 Investments (CSE:CXXI) Seems To Use Debt Quite Sensibly

Shareholder Returns

CXXICA PharmaceuticalsCA Market
7D16.7%-0.6%0.7%
1Y-44.2%-49.0%1.8%

Return vs Industry: CXXI exceeded the Canadian Pharmaceuticals industry which returned -51.8% over the past year.

Return vs Market: CXXI underperformed the Canadian Market which returned 0% over the past year.

Price Volatility

Is CXXI's price volatile compared to industry and market?
CXXI volatility
CXXI Average Weekly Movement16.4%
Pharmaceuticals Industry Average Movement14.4%
Market Average Movement9.8%
10% most volatile stocks in CA Market18.2%
10% least volatile stocks in CA Market4.2%

Stable Share Price: CXXI is more volatile than 75% of Canadian stocks over the past 3 months, typically moving +/- 16% a week.

Volatility Over Time: CXXI's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Canadian stocks.

About the Company

FoundedEmployeesCEOWebsite
1987n/aSonny Newmanhttps://www.cxxi.ca

C21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. It offers packaged and wholesale flower, vaporizer pens, cured extracts, edibles, pre-rolls, tinctures, and topicals; and payroll and benefits services. The company was formerly known as Curlew Lake Resources Inc. and changed its name to C21 Investments Inc. in November 2017.

C21 Investments Inc. Fundamentals Summary

How do C21 Investments's earnings and revenue compare to its market cap?
CXXI fundamental statistics
Market CapCA$46.22m
Earnings (TTM)CA$8.93m
Revenue (TTM)CA$40.93m

5.2x

P/E Ratio

1.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CXXI income statement (TTM)
RevenueUS$30.24m
Cost of RevenueUS$13.90m
Gross ProfitUS$16.34m
Other ExpensesUS$9.74m
EarningsUS$6.60m

Last Reported Earnings

Jul 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.055
Gross Margin54.02%
Net Profit Margin21.81%
Debt/Equity Ratio17.1%

How did CXXI perform over the long term?

See historical performance and comparison